Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator
- 31 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (21) , 3663-3669
- https://doi.org/10.1016/0006-2952(87)90017-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyransJournal of Medicinal Chemistry, 1986
- Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea‐pig taenia caeciBritish Journal of Pharmacology, 1986
- Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal veinBritish Journal of Pharmacology, 1986
- The relaxant action of nicorandil in guinea‐pig isolated trachealisBritish Journal of Pharmacology, 1986
- The Pharmacological and Physiological Role of Cyclic GMP in Vascular Smooth Muscle RelaxationAnnual Review of Pharmacology and Toxicology, 1985
- Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG-75)Journal of Cardiovascular Pharmacology, 1983
- Calcium channels: direct identification with radioligand binding studiesTrends in Pharmacological Sciences, 1982
- Adenosine 3′,5′-Monophosphate Content in Rat Caudate Nucleus: Demonstration of Dopaminergic and Adrenergic ReceptorsScience, 1974
- A new assay of cyclic nucleotide phosphodiesterase; its application to human serumBiochemical Medicine, 1974
- Adenosine 3′,5′-monophosphate phosphodiesterase assay in tissue homogenatesBiochimica et Biophysica Acta (BBA) - Enzymology, 1973